 |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394 |
|
|
|
 |
Synopsis for July 5, 2002
The MMWR is embargoed until 12 Noon, ET, Wednesday.
- Heat-Related Deaths ― Four States, JulyAugust 2001, and United States, 19791999
- Injuries and Deaths Among Children When Left Unattended In or Around Motor Vehicles ― United States, July
2000June 2001
- Certification of Poliomyelitis Eradication ― European Region, June 2002
- Vancomycin-Resistant Staphylococcus auerus ― Michigan, June 2002
Notice to Readers
Food and Drug Administration Approval of a Fifth Acellular Pertussis Vaccine for Use Among Infants and Young Children ― United
States, 2002
On May 14, 2002, the FDA approved the use of an additional combined diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP).
DAPTACEL is the fifth acellular pertussis vaccine to be licensed for use among infants and young children in the United States. Of these five
vaccines, three are distributed in the United States. DTaP is a safe and effective vaccine to protect infants and children from diphtheria,
tetanus, and pertussis (whooping cough).
Contact: Greg Wallace, MD, MPH
CDC, National Immunization Program
(404) 6398715
| Telebriefing, July 3, 2002 |
| WHO: |
Dr. Michael McGeehen, CDC environmental health expert, and Infectious disease speakers to be determined |
| WHAT: |
To discuss the MMWR articles on heat-related deaths and resistant Staphylococcus auerus. Brief remarks
followed by Q/A. |
| WHEN: |
Wednesday, July 3, 2002; NOON ET |
| WHERE: |
At your desk, by toll-free conference line: Dial 866-254-5942
Teleconference name: CDC |
| A full transcript will be available today following the teleconference at http://www.cdc.gov/media/.
This teleconference will also be audio webcast. Listen LIVE online at http://www.cdc.gov/media/.
|
|
Synopsis for July 5, 2002
Heat-Related Deaths ― Four States, JulyAugust 2001, and United States, 19791999
Heat-related illness can be prevented.
PRESS CONTACT:
Michael McGeehin, PhD
CDC, National Center for Environmental Health
(404) 4981300 |
|
Each year in the US, approximately 400 persons die from heat-related illnesses. Risk factors include young and old age, certain chronic and
mental illnesses, use of certain medications, strenuous exercise, social isolation, and being bed-ridden. Two important prevention measures are
spending some time in an air-conditioned environment and staying well hydrated with nonalcoholic beverages. Local public announcements and
response plans can help prevent heat-related illnesses. Young children and the elderly are at greatest risk for heat-related illness and death.
Heatstroke can occur in young healthy persons who are exercising or participating in strenuous activities in hot/humid weather conditions.
Spending time in an air-conditioned environment is the strongest factor in preventing heat-related illness.
Injuries and Deaths Among Children When Left Unattended In or Around Motor Vehicles ― United States, July 2000June
2001
Children who are left unattended in and around motor vehicles may be in harm's way.
PRESS CONTACT:
Office of Communications
CDC, National Center for Injury Prevention and Control
(770) 4884902 |
|
From July 1, 2000, through June 30, 2001, an estimated 9,160 non-fatal injuries and at least 78 fatal injuries occurred to children aged 14
years and younger who were left unattended in or near motor vehicles not in traffic. Many of these children suffered an injury or were killed
when they were backed over or run over by a motor vehicle; others died when they were left in a closed, hot vehicle. Drivers need to be alert
when pulling out or backing out of a driveway or parking lot because young children may be playing or standing in front of or behind the motor
vehicle. To ensure their safety, children should not be left unattended inside or near a motor vehicle even for a few seconds.
Certification of Poliomyelitis Eradication ― European Region, June 2002
On June 21, 2002, the European Region (EUR) became the third of six World Health Organization regions to be
certified as polio-free.
PRESS CONTACT:
Hamid Jafari, MD
CDC, National Immunization Program
(404) 63982526 |
|
The last known case of polio in EUR (comprised of 51 countries and a population of 873 million persons) caused by indigenous wild poliovirus
transmission occurred in southeast Turkey in November 1998. Since the initiation of the global polio eradication initiative in 1988 through
2001, the estimated annual incidence of polio globally decreased over 99% from 350,000 to less than 500. Until polio is eradicated globally, all
polio-free countries are at risk for wild poliovirus importation. Therefore, polio-free countries should maintain high levels of polio
vaccination coverage and surveillance for the prompt detection of any circulating poliovirus.
Vancomycin-Resistant Staphylococcus auerus ― Michigan, June 2002
Proper infection control and judicious use of antibiotics can go a long way to address the growing problem of antimicrobial resistance.
PRESS CONTACT:
Division of Media Relations
CDC, Office of Communication
(404) 6393286 |
|
This report describes the first clinical isolate of a vancomycin-resistant S. aureus. Although resistant to vancomycin, a drug commonly
used to treat certain S. aureus infections, this isolate is susceptible to several available antimicrobial drugs including linezolid and
quinopristindalopristin. Continued, aggressive efforts are necessary to detect the emergence of antimicrobial resistant microorganisms and
contain their spread. Such efforts include active case-finding through public health surveillance, the use of recommended infection control
practices, and the optimal use of antimicrobials in all healthcare settings. CDC is working with state and local health departments,
professional societies, and healthcare organizations on national initiatives to prevent antimicrobial resistance in healthcare settings.
|
